levamisole has been researched along with melphalan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| De Clercq, E; Gopalakrishnan, V; Gudibabande Narasimhamurthy, AK; Hegde, M; Karki, SS; Kumar, S; Raghavan, SC; Ramareddy, SA; Renuka, VK; Schols, D | 1 |
| Mason, B; Stephens, EJ; Wood, HF | 1 |
| Dmoszyńska, A; Kowalewski, J; Kraj, M; Kurowska, M; Maj, S; Mendek-Czajkowska, E; Pogłód, R; Rostkowska, J; Sokołowska, B; Sokołowska, U | 1 |
| Bonnet, J; Carter, S; Costanzi, JJ; Dabich, L; Dixon, DO; Durie, BG; Files, JC; Rivkin, S; Salmon, SE; Stephens, R | 1 |
| Ogawa, M | 1 |
| Arthur, JF; Hitchcock, GC; Kay, RG; Mason, BH; Mullins, P; Rodgers, R; Stephens, EJ; Trindall, PL | 1 |
| Alexanian, R; Dreicer, R | 1 |
| Jones, IS; Khoo, SK; Thomas, DA; Whitaker, SV | 1 |
| Di Saia, PJ; Gusdon, JP; Heise, ER; Herbst, GA; Homesley, HD; Lovelace, JV; Muss, HB; Richards, F; Spurr, CL | 1 |
| Azizov, RG; Burov, IuV; Merkulova, TI; Rogozhina, AT | 1 |
6 trial(s) available for levamisole and melphalan
| Article | Year |
|---|---|
Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis | 1978 |
[Chemotherapy and immunomodulating treatment of patients with multiple myeloma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon-alpha; Levamisole; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Remission Induction; Thymus Extracts; Vincristine | 1991 |
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Hematologic Diseases; Humans; Levamisole; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine | 1986 |
Levamisole in primary breast cancer. A controlled study in conjunction with l-phenylalanine mustard.
Topics: Age Factors; Breast Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukopenia; Levamisole; Lymphatic Metastasis; Melphalan; Menopause; Middle Aged; Placebos; Retrospective Studies; Thrombocytopenia | 1983 |
Chemotherapy for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Levamisole; Melphalan; Multiple Myeloma; Prednisone; Prognosis; Random Allocation; Vincristine | 1984 |
Levamisole as adjuvant to chemotherapy of ovarian cancer. Results of a randomized trial and 4-year follow-up.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Levamisole; Melphalan; Middle Aged; Neutropenia; Ovarian Neoplasms; Placebos; Random Allocation | 1984 |
9 other study(ies) available for levamisole and melphalan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cytotoxins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Imidazoles; Mice; Molecular Structure; Structure-Activity Relationship; Thiadiazoles | 2014 |
[US-Japan Cooperative Cancer Research Program--adjuvant and neo-adjuvant chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Levamisole; Lung Neoplasms; Melphalan; Neoplasms; Postoperative Care; Stomach Neoplasms | 1987 |
Chemotherapy of advanced ovarian epithelial carcinoma with melphalan and levamisole: a pilot study of the Gynecologic Oncology Group.
Topics: B-Lymphocytes; Drug Therapy, Combination; Female; Humans; Levamisole; Lymphocyte Activation; Melphalan; Middle Aged; Ovarian Neoplasms; Phytohemagglutinins; Pilot Projects; Pokeweed Mitogens; T-Lymphocytes | 1981 |
[A radiometric method for determining the effect of xenobiotics on murine bone marrow cell proliferation].
Topics: Adjuvants, Immunologic; Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Levamisole; Male; Melphalan; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Polysorbates; Radiometry; Uracil; Xenobiotics | 1995 |